Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ128912930,00
KB10341036-0,38
PKN86,4386,47-0,05
Msft0,65
Nokia4,0574,061-0,49
IBM0,84
Mercedes-Benz Group AG53,4853,510,19
PFE6,83
01.10.2025 9:48:26
Indexy online
AD Index online
select
AD Index online
 

  • 30.09.2025
Bom CRP-3 (Toronto)
Závěr k 30.9.2025 Změna (%) Změna (CAD) Objem obchodů (CAD)
17,49 -0,06 -0,01 -
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 01.10.2025
Popis společnosti

Business Summary: Bombardier Inc. is a Canada-based company, which designs, builds, modifies and maintains aircraft for the people and businesses, governments, and militaries. In addition to the Company's portfolio of large and medium business jets, it is also outfitting various aircraft platforms for specialized mission use through Bombardier Defense. Its jets include Global 8000, Global 7500, Global 6500, Global 5500, Challenger 650 and Challenger 3500. Its pre-owned categories include pre-owned inventory, pre-owned sales & acquisition, certified pre-owned and pre-owned market report. Bombardier Defense’s mission types include Head of State, ISR & AEW, maritime surveillance, medevac, search and rescue, flight inspection system, weather/atmospheric observation and multi-role. Its customers operate a fleet of more than 5,100 aircraft and 10 service facilities across six countries. Its jets are manufactured in aerostructure, assembly and completion facilities in Canada, the United States and Mexico.
Financial Summary: BRIEF: For the six months ended 30 June 2025, Bombardier Inc revenues increased 2% to $3.55B. Net income applicable to common stockholders excluding extraordinary items increased 97% to $223M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Losses on repayments of long-term debt decrease of 48% to $66M (expense).



  • Poslední aktualizace: 01.10.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Executive DirectorPascal Soriot6501.10.201201.10.2012
Chief Financial Officer, Executive DirectorAradhana Sarin-01.08.202101.08.2021
Chief Executive Officer - Alexion, Chief Strategy Officer - AstraZenecaMarc Dunoyer7201.08.202101.01.2013
Chief Human Resources Officer, Chief Compliance Officer, General CounselJeffrey Pott-01.01.2009
Executive Vice President - BioPharmaceuticals R&DSharon Barr-
Executive Vice President - Global Operations, Information Technology and Chief Sustainability OfficerPam Cheng-
Executive Vice President - BioPharmaceuticals Business UnitRuud Dobber60
Executive Vice President - Oncology Business UnitDavid Fredrickson50
Executive Vice President - Oncology and Research and DevelopmentSusan Galbraith-
Executive Vice President, InternationalIskra Reic-04.12.2024